See also this year's filing and all EDGAR filings for this company.
PDF Report 0001604191_2023_First_Wave_BioPharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 15, '002001 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Calc2)': 5}} |
Graph
Absolute values for 0001604191, First Wave BioPharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,412,755 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,684,182 |
| 2 | PropertyPlantAndEquipmentNet | 43,839 |
| 3 | remainder_Assets | 298,923 |
| 4 | LiabilitiesCurrent | 2,483,487 |
| 5 | LiabilitiesNoncurrent | 214,060 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,986,809 |
| 9 | ResearchAndDevelopmentExpense | 8,776,302 |
| 10 | remainder_Expenses | -8,085,045 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,951,576 |
| 13 | remainder_ComprehensiveNetIncome | 1,224,135 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,439,699 |
| 1 | Liabilities | 2,697,547 |
| 2 | Expenses | 12,678,066 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 2,742,152 |
| 5 | NetIncome | -14,629,642 |
| 6 | ComprehensiveNetIncome | -14,017,574 |
| 7 | BaseVar | 11,995,512 |
| 8 | EconomicCapitalRatio | -2.29 |
Edgar->Model Mapping
Feature Distribution
Change over Time
